What was recalled
The U.S. Food and Drug Administration has announced a Class II recall involving specific medication delivery components manufactured by ICU Medical, Inc. The affected items are the CADD Yellow Medication Cassette Reservoirs equipped with NRFit connectors. These devices are critical parts of infusion therapy systems, designed to hold and dispense medications precisely into a patient’s body. While they may seem like simple plastic containers, their engineering is vital for ensuring that life-saving drugs are delivered at the correct rate and volume without interruption. The recall focuses on products distributed both within the United States and internationally, highlighting the widespread nature of this specific manufacturing batch.
To help you identify whether your unit is part of this recall, it is essential to look closely at the product codes printed on the packaging or the device itself. For the U.S. market, the affected products carry the specific US Product Codes 21-7600-24 and 21-7609-24. It is important to note that these same alphanumeric codes also appear in the list of OUS (Outside the United States) Product Codes. This overlap means you cannot rely solely on the code numbers to determine if an item was sold domestically; you must cross-reference this with the lot numbers and distribution history provided below.
The scope of this recall covers a significant number of units across multiple countries. Within the United States, the products were distributed nationwide but specifically noted in the states of Arkansas, California, Florida, Illinois, Indiana, Louisiana, Michigan, Missouri, Mississippi, Tennessee, Texas, Virginia, and Wisconsin. Internationally, the affected reservoirs reached markets in Austria, Australia, Belgium, Costa Rica, Germany, Estonia, Spain, Finland, France, Great Britain, Ireland, Italy, Japan, Kuwait, the Netherlands, Norway, and Sweden. The recall was initiated on August 20, 2026, marking the date when FDA became aware of the potential safety issue and the company began its remediation process.
If you are trying to verify if your specific cassette is included in this recall, you will need to check two key identifiers: the Unique Device Identifier (UDI) Direct Identification number and the Lot number. For the product with UDI-DI 30610586044001 (associated with code 21-7600-24), the recall affects lots numbered 6026878, 6037784, 6054015, 6062724, 6070616, 6082332, 6092886, 6101906, 6108556, 6126029, 6140893, 6143454, 6147696, 6147697, 6162769, 6155095, 6166032, 6171587, and 6171586. For the product with UDI-DI 30610586044018 (associated with code 21-7609-24), the affected lots are 6022079, 6037697, 6037698, 6053978, 6061525, 6072970, 6072964, 6070575, 6077773, 6092846, 6101798, 6108514, 6108515, 6108516, 6140862, 6140861, 6140865, and 6155132. Additionally, the recall lists specific codes with a "JP" suffix (21-7600-24JP and 21-7609-24JP) as part of the OUS product codes, indicating international variants are also implicated in this safety notice.
The hazard, explained
To understand why this recall matters, we first need to look at how the CADD Yellow Medication Cassette Reservoir is supposed to work and where that process can go wrong. These reservoirs are designed to hold medication for infusion pumps, which deliver precise amounts of liquid into a patient’s body over time. The system relies on a tight seal between the luer connector (the part you plug into the tubing) and the tubing itself. Think of it like a garden hose connection: if the threads or seals don’t match perfectly, water sprays out instead of flowing where it should. In this case, the "water" is medication that might be critical for treating an infection, pain, or heart condition.
The specific physical failure identified by the FDA involves leakage at the joint between the luer connector and the tubing. This isn’t just a minor drip; it’s a breach in the system’s integrity. When this joint fails, several dangerous things can happen simultaneously. First, medication may leak out of the connection point. This means the patient receives less medicine than prescribed (under-delivery), which could allow an illness to worsen or pain to remain unmanaged. Second, if the seal breaks completely, air can enter the tubing line. When air travels into a vein, it causes an air embolus—a blockage that can be life-threatening by stopping blood flow to vital organs like the heart or lungs.
There is also a significant risk of exposure to infectious or toxic agents. If medication leaks onto surfaces, skin, or into the environment, healthcare workers or caregivers could be exposed to potent drugs they were not intending to handle. Conversely, if the leak allows outside contaminants to enter the line, bacteria or other pathogens could be introduced directly into the patient’s bloodstream. This is especially concerning in intensive care settings where patients often have compromised immune systems.
Finally, even a small leak can cause delays or interruptions in therapy. Infusion pumps are calibrated to deliver exact doses. If fluid escapes before reaching the patient, the pump may not register the correct volume, leading to incorrect dosing records and potential treatment errors. While general medical knowledge tells us that most device recalls are precautionary, this particular hazard involves direct physical failure points that can lead to immediate clinical consequences, including tissue damage from leaked medication or serious cardiovascular events from air emboli.
Who is most at risk
To understand who is truly vulnerable in this recall, we first need to look at the setting where these devices are used. The ICU Medical CADD Yellow Medication Cassette Reservoir with NRFit connector is a specialized component designed for use with infusion pumps, specifically those found in critical care environments like Intensive Care Units (ICUs), operating rooms, and emergency departments. This is not a product you will find in a typical home medicine cabinet or used by patients managing routine chronic conditions at home. The primary "owners" of these devices are healthcare facilities and the medical professionals who operate them—nurses, respiratory therapists, and physicians—who rely on the precise delivery of potent medications to stabilize patients.
The individuals most at risk from this specific defect are those receiving continuous or high-acuity intravenous therapies. Because the hazard involves medication leakage at the joint between the luer connector and tubing, the risk is twofold: it affects the patient’s treatment efficacy and their physical safety. Patients in these settings are often critically ill, immunocompromised, or undergoing complex procedures where even a brief interruption in therapy can have severe consequences. For example, if a patient is receiving vasopressors to maintain blood pressure, or insulin to control glucose levels, an under-delivery caused by leakage could lead to rapid clinical deterioration. The recall notice highlights that this issue could result in a delay or interruption of therapy, which is particularly dangerous for patients who cannot tolerate fluctuations in their medication levels.
Beyond the immediate risk of ineffective treatment, the physical hazards posed by the leakage are significant. The recall states that the defect could lead to exposure to infectious or toxic agents. For patients with weakened immune systems, such as those in oncology wards or post-transplant care, any breach in the sterile integrity of the delivery system increases the risk of infection. Furthermore, the potential for an air embolus—a dangerous condition where air enters the bloodstream—is a serious threat to anyone whose cardiovascular system is already under stress. While the device is designed for professional use, the ultimate victims of this manufacturing flaw are the patients who depend on the reliability of every component in their life-support or critical care equipment.
It is also important to note that while the distribution pattern includes countries such as Austria, Australia, Germany, and Japan, as well as numerous U.S. states, the risk is concentrated in facilities that have stocked these specific lots. The affected lots include 6026878, 6037784, and others listed in the FDA report. Healthcare administrators and clinical staff in these regions must be vigilant because the risk is not about who *uses* the device generally, but whether their facility has received one of the specific contaminated batches. For the general public, the risk is virtually zero; however, for any patient currently receiving IV therapy through an ICU Medical CADD pump in the listed distribution areas, this recall represents a direct and immediate safety concern that requires urgent verification.
How to tell if you have the recalled item
Identifying whether your specific medical device is part of this recall requires careful attention to several distinct details on the packaging and the device itself. Because ICU Medical, Inc. has issued a Class II recall for the CADD Yellow Medication Cassette Reservoir with NRFit connector, you cannot rely on general descriptions alone. You must verify exact product codes, unique device identifiers (UDI-DI), and specific lot numbers to ensure accuracy.
First, locate the physical cassette. The product is visually identified by its yellow color and the presence of an NRFit connector. However, color alone is not enough for confirmation, as other medical supplies may look similar. Look closely at the label or packaging for the US Product Codes. The recall specifically targets items with the codes 21-7600-24 and 21-7609-24. These codes are critical markers that distinguish the affected units from other CADD series products.
Next, you must examine the Unique Device Identifier (UDI-DI) and the Lot Number. These are typically printed on the sterile barrier packaging or directly on the device label. For the product code 21-7600-24, the UDI-DI is 30610586044001. If your device bears this UDI-DI, you must then check if the Lot Number matches one of the following: 6026878, 6037784, 6054015, 6062724, 6070616, 6082332, 6092886, 6101906, 6108556, 6126029, 6140893, 6143454, 6147696, 6147697, 6162769, 6155095, 6166032, 6171587, or 6171586.
If your device has the product code 21-7609-24, the UDI-DI will be 30610586044018. In this case, verify if the Lot Number is one of these: 6022079, 6037697, 6037698, 6053978, 6061525, 6072970, 6072964, 6070575, 6077773, 6092846, 6101798, 6108514, 6108515, 6108516, 6140862, 6140861, 6140865, or 6155132.
Remember that this recall affects products distributed worldwide, including across the United States and in countries such as Austria, Australia, Belgium, Costa Rica, Germany, Estonia, Spain, Finland, France, Great Britain, Ireland, Italy, Japan, Kuwait, Netherlands, Norway, and Sweden. If you are in the U.S., distribution occurred in states like AR, CA, FL, IL, IN, LA, MI, MO, MS, TN, TX, VA, and WI. The recall was initiated on August 20, 2026. If your device matches any of the codes and lot numbers above, stop using it immediately and contact ICU Medical or your healthcare provider for further instructions.
What to do — step by step
If you are currently using the recalled ICU Medical CADD Yellow Medication Cassette Reservoirs equipped with an NRFit connector, your immediate priority is to prioritize patient safety above all else. The FDA has classified this recall as a Class II event, which indicates that while the situation is serious and could lead to significant health risks such as medication leakage, delayed therapy, or even air embolus, it is not typically life-threatening in every single instance if handled correctly. However, because the specific remedy—whether that involves returning the units for a refund, receiving a repair kit, or getting a replacement—is not stated in the current official recall notice, you cannot assume there is an automated process waiting for you. You must take proactive control of this situation to ensure no harm comes to the patient relying on this device. First and foremost, you must stop using any affected inventory immediately. Do not attempt to use these cassettes for new patients or to top off existing infusions until you have verified their status. The hazard involves potential leakage at the joint between the luer connector and the tubing, which can lead to under-delivery of critical medication or exposure to toxic agents. If a patient is currently connected to a device containing one of these reservoirs, consult with the attending physician or clinical pharmacist right away to determine if the therapy needs to be paused, switched to a different pump model that uses compatible cassettes, or managed in another safe way. Do not try to fix the leak yourself; this is a manufacturing defect involving the joint integrity, and field repairs are not authorized without explicit instructions from the manufacturer. Next, you need to identify exactly which units you have in your possession. This recall affects specific U.S. and Overseas (OUS) product codes, primarily 21-7600-24 and 21-7609-24. You must check the Unique Device Identifier (UDI-DI) on the packaging or the device label. For the UDI-DI 30610586044001, look for lots including 6026878, 6037784, 6054015, 6062724, 6070616, 6082332, 6092886, 6101906, 6108556, 6126029, 6140893, 6143454, 6147696, 6147697, 6162769, 6155095, 6166032, and 6171587. For the UDI-DI 30610586044018, check for lots 6022079, 6037697, 6037698, 6053978, 6061525, 6072970, 6072964, 6070575, 6077773, 6092846, 6101798, 6108514, 6108515, 6108516, 6140862, 6140861, 6140865, and 6155132. If your inventory matches these codes and lot numbers, they are part of the recall scope. Finally, because the official remedy is not stated, you must contact ICU Medical directly to find out how to proceed with disposal or replacement. Reach out to their customer service or medical device support team using the contact information provided in the full FDA recall notice. Ask specifically about the return process, any potential reimbursement for lost product costs, and instructions for the safe disposal of the recalled reservoirs. Do not throw them in the regular trash; follow the manufacturer’s guidance for hazardous medical waste if applicable. Keep records of all communications with ICU Medical and document the units you removed from service to protect your facility from liability and ensure compliance with FDA regulations.Your refund, repair, or replacement options
If you are in possession of the recalled CADD Yellow Medication Cassette Reservoirs with NRFit connectors, your immediate priority should be to secure a safe and functional replacement for your medical needs. According to the official recall notice issued by the FDA on August 20, 2026, ICU Medical, Inc. has initiated this Class II recall due to potential medication leakage at the joint between the luer connector and tubing. While the specific details regarding the exact nature of the remedy—whether it involves a direct refund, a repair service, or a straightforward replacement unit—are not explicitly detailed in the public record provided here, standard protocol for medical device recalls of this nature typically involves the manufacturer providing replacement units to ensure patient safety without financial penalty.
The most critical step you must take is to stop using these specific cassettes immediately. Because the hazard involves potential under-delivery of medication or exposure to infectious agents, continuing to use a compromised reservoir poses a direct threat to health outcomes. You should contact ICU Medical, Inc., directly to initiate the return process. Although the specific phone numbers, email addresses, or web portals for this recall are not listed in the available facts, you can locate their official customer support channels by visiting the FDA’s official recall database or the ICU Medical website. When you reach out, have your product codes and lot numbers ready, as these are essential for verifying that your specific unit is part of the affected batch.
To ensure you receive the correct remedy, you will need to provide precise identification details. The recall affects U.S. Product Codes 21-7600-24 and 21-7609-24, as well as various Overseas (OUS) product codes including those with JP suffixes. Furthermore, the recall is limited to specific lots identified by their Unique Device Identification (UDI-DI) numbers. For UDI-DI 30610586044001, affected lots include 6026878, 6037784, 6054015, and many others up to 6171586. For UDI-DI 30610586044018, affected lots include 6022079, 6037697, 6037698, and others up to 6155132. Verifying your lot number against these lists is crucial because units outside these specific ranges are likely safe and do not require action.
Once you have confirmed your unit is recalled, ICU Medical will guide you through the return process. Typically, this involves shipping the defective items back to them at no cost to you. In exchange, they generally provide a replacement reservoir that has been inspected and certified to meet safety standards. If the recall was due to a manufacturing defect that cannot be easily repaired in the field, a replacement is the most common remedy. If you have questions about reimbursement for any costs incurred or need clarification on the return shipping label, these details will be outlined in the official communication from ICU Medical. Do not attempt to dispose of the recalled items in regular trash; follow the manufacturer’s instructions for proper disposal to prevent accidental use by others.
What can happen if you ignore it
When a medical device recall involves the delivery of life-sustaining or critical medications, the stakes are inherently high because the consequences extend far beyond simple inconvenience. In the case of the ICU Medical CADD Yellow Medication Cassette Reservoir with NRFit connector, ignoring this recall means continuing to rely on a component that has been identified as physically compromised. The core issue is a potential failure at the joint between the luer connector and the tubing. While a small leak might seem manageable in a non-medical context, in an intensive care setting where precise dosing is paramount, even minor deviations can cascade into serious clinical events.
The most immediate danger of using a leaking reservoir is the interruption or delay of therapy. These cassettes are often used to deliver medications that require strict timing and volume accuracy, such as vasopressors for blood pressure control, insulin for glucose management, or potent analgesics. If the reservoir leaks, the pump may not deliver the full prescribed dose. This "under delivery" can lead to a sudden drop in therapeutic efficacy. For a patient whose condition is stable only because of that precise medication flow, an abrupt reduction in dosage can cause their vital signs to deteriorate rapidly. In critical care, minutes matter; a delay in treatment can mean the difference between maintaining stability and requiring emergency intervention.
Beyond the failure to deliver medicine, the leak itself introduces foreign elements into the system. If the seal fails, there is a risk that infectious agents or toxic contaminants from the environment could enter the medication stream. This compromises the sterility of the infusion, potentially leading to bloodstream infections or other complications for patients who are already immunocompromised or critically ill. Furthermore, if air enters the line due to the leakage or subsequent pump errors, there is a risk of an air embolus. An air embolus occurs when air bubbles travel through the bloodstream and block blood flow, which can be fatal depending on where the air lodges. While these severe outcomes are not guaranteed in every instance of leakage, the mechanism by which they occur is directly tied to the physical defect described in this recall.
It is important to understand that medical device recalls are proactive measures taken when a defect is found before widespread harm occurs, or when the risk of harm is significant enough to warrant immediate action. By ignoring this notice, you are essentially betting that the specific lot you have does not exhibit the leakage issue. However, because manufacturing defects can vary even within the same production run, there is no reliable way for a user to visually confirm that a specific unit is safe without professional inspection. Continuing to use these devices undermines the safety protocols designed to protect patient health. The potential consequences—ranging from ineffective treatment to life-threatening complications—are not theoretical; they are the direct result of the mechanical failure identified by ICU Medical and the FDA. Prioritizing your safety means acting on this information immediately, rather than hoping the defect does not manifest in your specific situation.
Staying safe: broader tips
When dealing with medical devices like infusion pumps and their associated consumables, vigilance is your best defense against unexpected interruptions in care. While manufacturers strive for perfection, mechanical components can occasionally fail due to subtle manufacturing variances or wear over time. To minimize the risk of medication errors or device failures, start by becoming intimately familiar with your specific equipment. Take a few minutes to read the user manual not just once, but periodically. Understanding how your pump connects to its reservoirs, where the secure points are, and what normal operation sounds and looks like allows you to spot anomalies immediately. If a connection feels loose or the display behaves strangely, trust your instincts and inspect the hardware before proceeding.
Regular inspection of all consumable parts is equally critical. Before every use, visually check tubing for cracks, kinks, or discoloration, and ensure that connectors are free of debris or damage. Luer locks and NRFit connectors rely on precise alignment to create a seal; even minor warping or residue can compromise this seal, leading to the very leakage issues described in recent recalls. If you notice any wear on the plastic housing or if the locking mechanism does not click firmly into place, replace the component immediately. Do not attempt to tape or modify connectors to make them fit better, as this introduces significant risk of air embolism or incorrect dosing.
It is also wise to establish a proactive routine for staying informed about safety updates. Set up alerts on the FDA’s official database or sign up for email notifications from the manufacturers whose equipment you use. Recalls often target specific lots that may not be immediately obvious, so having direct access to this information ensures you can act quickly if your device is affected. Additionally, never ignore unusual alarms or error messages. Modern pumps are equipped with sophisticated sensors designed to detect flow restrictions, air in the line, or empty reservoirs. If a pump alarms frequently, it is signaling a problem that needs resolution, not just a nuisance to be silenced.
- Verify connections: Always double-check that all tubing and connectors are fully seated and locked before starting therapy.
- Monitor the site: Regularly check the patient’s insertion site for signs of infiltration or leakage, which can indicate a failure in the delivery system upstream.
- Keep records: Maintain a log of your device’s serial numbers and lot codes. This makes it much easier to verify recall status if an announcement is made later.
- Report issues: If you suspect a device malfunction, report it to the manufacturer via MedWatch or your local regulatory agency. Your feedback helps improve future designs and protects other patients.
Finally, remember that technology is only as safe as the user’s attention to detail. By combining regular maintenance, up-to-date knowledge of safety alerts, and careful observation during use, you create a robust layer of protection. This approach ensures that your focus remains on patient care rather than troubleshooting preventable mechanical failures.